BioCentury | Oct 7, 2013

4Q Financial Markets Preview: Totally baked

...REGN727) Hypercholesterolemia Top-line Ph III MONO data 4Q13 Salix Pharmaceuticals Inc. (NASDAQ:SLXP)/Dr. Falk Pharma GmbH Budenofalk...
BioCentury | Jan 21, 2013
Clinical News

Budenofalk budesonide gastro-resistant capsule regulatory update

...The Scottish Medicines Consortium recommended the use of Dr. Falk's Budenofalk budesonide gastro-resistant capsule on the National Health...
...Salix Pharmaceuticals Inc. (NASDAQ:SLXP), Raleigh, N.C. Dr. Falk Pharma GmbH , Freiburg, Germany Product: Budenofalk budesonide gastro-resistant capsule...
BioCentury | Mar 17, 2008
Company News

Dr. Falk Pharma, Salix deal

...this year or early in 2009 for an inflammatory bowel disease (IBD)-related indication, and a budesonide gastro-resistant capsule...
Items per page:
1 - 3 of 3